Amryt Pharma (AMYT)

Sector:

Financials

Index:

FTSE AIM All-Share

179.50p
   
  • Change Today:
      0.50p
  • 52 Week High: 223.00
  • 52 Week Low: 148.00
  • Currency: UK Pounds
  • Shares Issued: 316.50m
  • Volume: 4,159
  • Market Cap: 568.11m

Amryt Pharma Overview

Amryt Pharma is in the financials sector and is currently trading at 179.50p per share. In the last year Amryt Pharma's share price has ranged from 148.00p to 223.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -25.4% -39.0%
ROCE 230.7%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 4.3 3.6
Pr/Book 11.8  
Latest F'cast
Revenue 214.2% -36.2%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Amryt Pharma Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 1.35 (7.80) (28.68)¢ n/a n/a n/a n/a 0.0%
31-Dec-17 12.78 (26.14) (70.32)¢ n/a n/a n/a n/a 0.0%
31-Dec-18 17.09 (30.44) (402.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-19 58.12 (63.49) (83.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-20 182.61 (105.86) (66.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Amryt Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 159.11 (62.13) (7.34)p n/a n/a n/a n/a 0.0%
31-Dec-22 259.67 24.74 7.89p 22.7 n/a n/a n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Amryt Pharma Company Announcements

Amryt Raises Full Year 2021 Revenue Guidance to ... 13-Sep-2021 12:00 GlobeNewswire NA
Total Voting Rights 01-Sep-2021 07:00 GlobeNewswire NA
Amryt Issues Ordinary Shares and Total Voting Ri... 19-Aug-2021 07:00 GlobeNewswire NA

Latest Amryt Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Amryt Pharma Market Data

Currency UK Pounds
Share Price 179.50p
Change Today 0.50p
% Change 0.28 %
52 Week High 223.00
52 Week Low 148.00
Volume 4,159
Shares Issued 316.50m
Market Cap 568.11m

Amryt Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
62.23% below the market average62.23% below the market average62.23% below the market average62.23% below the market average62.23% below the market average
52.24% below the sector average52.24% below the sector average52.24% below the sector average52.24% below the sector average52.24% below the sector average
Price Trend
42.92% below the market average42.92% below the market average42.92% below the market average42.92% below the market average42.92% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Income Not Available
Growth
65.97% above the market average65.97% above the market average65.97% above the market average65.97% above the market average65.97% above the market average
70.25% above the sector average70.25% above the sector average70.25% above the sector average70.25% above the sector average70.25% above the sector average

What The Brokers Say

Strong Buy 7
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Amryt Pharma Dividends

No dividends found

Trades for 24-Sep-2021

Time Volume / Share Price
12:51 700 @ 177.56p
10:34 3,000 @ 177.40p
09:00 434 @ 182.90p
08:08 25 @ 176.98p

Amryt Pharma Key Personnel

CEO Joe Wiley

Top of Page